Indonesia's healthcare sector is set to see continued support from PT Prodia Diagnostic Line Tbk (Proline), which has just raised $3.9M. The company, established in 2010, manufactures and supplies a wide array of in vitro diagnostic (IVD) products, from clinical chemistry reagents to IVD instruments, to over 7,000 healthcare facilities across the archipelago.
Proline prides itself on its significant local content, exceeding 40% for most products, as it strives to be Indonesia's comprehensive IVD manufacturer. Its certifications, including ISO 13485:2016, underscore its commitment to quality in a critical medical supply chain.
